Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antimicrobial and antiparasitic agents. Its nitroimidazole core structure supports activity against anaerobic bacteria and certain protozoa. The methylsulfonyl group enhances solubility and influences pharmacokinetic properties, making it valuable in optimizing drug candidates. It is also employed in research settings to explore new bioactive molecules and structure-activity relationships within imidazole-based derivatives.